De-Escalation of P2Y(12) Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention

Dual antiplatelet therapy (DAPT) — a combination of a P2Y(12) receptor inhibitor and aspirin — has revolutionized antithrombotic treatment. Potent P2Y(12) inhibitors such as prasugrel and ticagrelor exhibit a strong and more consistent platelet inhibition when compared to clopidogrel. Therefore, tic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kupka, Danny, Sibbing, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158449/
https://www.ncbi.nlm.nih.gov/pubmed/30238704
http://dx.doi.org/10.4070/kcj.2018.0255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158449/
https://www.ncbi.nlm.nih.gov/pubmed/30238704
http://dx.doi.org/10.4070/kcj.2018.0255

Ejemplares similares